DRUGS MADE IN AMERICA ACQ II CORP
- Market cap
- 649.10M
- P/E (TTM)i
- 34.90
- P/Bi
- 1.31
- EPSi
- 0.15
- Div yieldi
- 0.00%
- 52W posi
- 70%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 76.94% +0.01pp
- Institutions
- 74 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-04-15
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
10 filings tracked · 6 buys · 2 sells
| Name | Role | Stake |
|---|---|---|
| Glenn Worman | Chief Financial Officer | 0.16% |
| Myron Shulgan | Independent Director | 0.16% |
| Sridhar Prasad | Independent Director | 0.16% |
| Catherine Do | Independent Director | 0.16% |
| Drugs Made In America Acquisition II LLC | -- | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2025-09-25 | Glenn Worman | Chief Financial Officer | Other Acquisition | +100,000 | -- |
| 2025-09-25 | Sridhar Prasad | Independent Director | Other Acquisition | +100,000 | -- |
| 2025-09-25 | Catherine Do | Independent Director | Other Acquisition | +100,000 | -- |
| 2025-09-25 | Myron Shulgan | Independent Director | Other Acquisition | +100,000 | -- |
| 2025-09-25 | Drugs Made In America Acquisition II LLC | -- | Other Disposition | -400,000 | -- |
| 2025-09-25 | Drugs Made In America Acquisition II LLC | -- | Private Acquisition | +700,000 | -- |
| 2025-09-25 | Drugs Made In America Acquisition II LLC | -- | Private Disposition | -7,966,667 | -- |
| 2025-09-25 | Drugs Made In America Acquisition II LLC | -- | Open Market Derivative Acquisiti | +700,000 | -- |
| 2025-09-23 | Drugs Made In America Acquisition II LLC | -- | Initial Statement of Beneficial | 0 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.